A recent study indicates that individuals who discontinue blockbuster weight-loss injections like Mounjaro or Wegovy may regain reduced body mass far faster than those who halt traditional lifestyle programs.
Published data in a major health publication shows that while overweight people can lose substantial amounts of their total mass while undergoing treatment, the mass comes back at an average rate of nearly a kilo each month after stopping.
"Individuals purchasing these medications must be cognizant of the potential of quick rebound weight gain when the treatment ends," cautioned researcher Dr. Susan Jebb.
That rate of regain suggests a reversion to starting mass within about 18 months.
Analyzing Treatments
The analysis, which looked at dozens of trials involving over 9,000 of patients, contrasted the outcomes of the injectable medications with conventional dieting.
The team emphasize that individuals who lose weight through diet and exercise usually see a slower weight regain—approximately 100 grams monthly—once they finish.
Explaining the Fast Regain
Nutrition scientists suggest the way of the drugs accounts for the heightened rebound.
GLP-1 drugs copy a natural hormone called GLP-1, which helps regulate appetite.
"Artificially providing the hormone concentrations far above than normal may cause the system to produce less of its own natural GLP-1, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher.
"Stopping of this GLP-1 'fix' means hunger is no longer kept in check, making overeating much more probable."
An Ongoing Disease?
Health authorities recommend the jabs for people with weight-linked medical conditions, alongside recommended lifestyle changes.
A number of clinicians say that, given the likelihood of relapse, the therapy should be considered life-long.
This opinion is echoed by drug manufacturers, who say that the results "underscore the persistent character of obesity," akin to managing diseases like hypertension.
User Testimonies
People who have come off the jabs describe a powerful resurgence of cravings.
"I experienced a switch activating and I was suddenly extremely hungry," recalled a patient.
This challenge is exacerbated if patients have not established lasting lifestyle or habit modifications during therapy.
Growing Adoption
Figures indicate that millions of adults in the UK have used weight-loss jabs in the past year, with desire continuing to grow.
- Adoption is greater among women than men.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion access the medications through private healthcare rather than public health services.
Finally, researchers stress that while the jabs are effective agents for shedding pounds, they are not a standalone solution and maintained weight loss hinges on integrated lifestyle changes.
